826 Risk of COVID-19 infection among patients receiving immune checkpoint inhibitor therapy: a tertiary care hospital system collaboration with the Massachusetts department of health

• Vartan Pahalyants,
• Nikolai Klebanov,
• Nicholas Theodosakis,
• Monina Klevens,
• Evelyn Lilly,
• Yevgeniy Semenov

Affiliations

Vartan Pahalyants

1Harvard Medical School, Chestnut Hill, MA, USA

Nikolai Klebanov

2Massachusetts General Hospital, Boston, MA, USA

Nicholas Theodosakis

2Massachusetts General Hospital, Boston, MA, USA

Monina Klevens

3Mass Department of Public Health, Boston, MA, USA

Evelyn Lilly

2Massachusetts General Hospital, Boston, MA, USA

Yevgeniy Semenov

2Massachusetts General Hospital, Boston, MA, USA